Abstract
Background The 2019 coronavirus disease pandemic (COVID-19) spread rapidly across Brazil. The country has 27 federative units, with wide regional differences related to climate, lifestyle habits, socioeconomic characteristics and population density. Therefore, we aimed to document and monitor the increase in COVID-19 cases across each federative unit in Brazil, by tracking its progression from inception to 15 May 2020.
Methods Observational study.
Results The first confirmed COVID-19 case in the country was notified in São Paulo on 26 February, while the first death occurred on 17 March, in Rio de Janeiro. Since then, there has been a dramatic increase in both confirmed cases and deaths from the disease. São Paulo, in the Southeast region, was initially considered the COVID-19 epidemic epicentre in Brazil. However, 10 states in the North and Northeast regions were ranked among the 14 highest incidences (over 100 cases per 100,000 people) observed on 15 May. Higher incidence rates (>100 cases per 100,000) were associated to higher rates of inadequate water supply and sewerage (OR, 5.83 (95% CI, 1.08–29.37, P=0.041)). North and Northeast states with the highest social vulnerability index scores had higher increases in the incidence rate between 14 April and 15 May. States with medium human development index (HDI) showed higher incidence increases from 14 April to 15 May, being seven of them with ratios in the range from 27.49 to 63.73 times.
Conclusion Spreading of COVID-19 in Brazil differs across both regions and federative units, being influenced by different socioeconomic contexts.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
The author(s) received no specific funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In this study, only public domain data was used, without identifying personal data. According to the Resolution number 510/2016 from Brazilian legislation of the National Health Council (Conselho Nacional de Saude (CNS)), no ethical approval is required under Ethics Committee on Research (Comite de Etica em Pesquisa (CEP) and National Ethics Commission (Comissao Nacional de Etica (Conep))
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos